Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tetra Bio Pharma is developing HU-308, in Phase I, for dry eyes and uveitis and, as a parenteral formulation, for the potential treatment of cytokine release syndrome and the potential prevention and treatment of SARS-COV-2 acute respiratory disease
Its also suggested that you only give the injection under the supervision of a medical professional
Subcutaneous or intramuscular administration of BPC-157 and TB-500 may augment their therapeutic effects
Specifically, understanding the optimal KLOW dosage guide for various research models and objectives
US$ 28.81
US$ 27.01
US$ 25.49
US$ 27.25
US$ 28.91
US$ 26.39
